Press Release FeedGet the RSS feed
Menu

Browse press releases

The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.

5,214 resultsPage 66 of 435, newest first
  1. AIHisenseHisense Brings AI Companion Suite to Life with a Social KitchenCompanies: HisenseHisense, a leading brand in global consumer electronics and home appliances, is bringing its vision of "Innovating a Brighter Life" into the heart of the home with the new PureSmart Duo Series — a refrigerator series designed as the intelligent...
  2. AI苹果Home Hub传闻升温 家庭AI中枢的落地赛已开启香港, 2026年10月9日 - (亚太商讯) - 近期，据多家媒体援引 Bloomberg 报道，苹果可能推出由 Siri AI 驱动的家庭中枢产品。围绕“Home Hub”的讨论升温，再次让家庭 AI 中枢成为科技行业关注的焦点。 这背后所指向的，并不只是一台带屏幕、带语音的新硬件。家庭正在成为 AI 从数字世界走向真实物理场景的重要入口：它需要连接分散的设备、理解家庭成员与场景，并协调娱乐、安防、信息与日常服务。家庭 AI 中枢的核心竞争，也正在从“设备互联”走向“智能体、终端与服务的协同”。 这一趋势，与华曦达正在推进的 AI Home 路径高度契合。依托长期积累的家庭视讯、OTT、Android TV 等终端和平台能力，华曦达正把原有的家庭娱乐入口延展为面向 AI Home 的服务承载节点——AI Home Hub。 华曦达所探索的，不是为传统设备简单叠加 AI 功能，而是以家庭终端为触点，连接云端智能、家庭设备、内容
  3. AINWB Finland Oy to Expands U.S. Retail Presence With AINA Natural Water Coming Soon to AmazonBoca Raton, Florida Friday Oct 9, 2026 @ 4:00 AM Eastern — NWB Finland Oy is continuing its planned U.S. rollout of AINA Natural Water, announcing that the Finnish premium water brand is coming soon to Amazon. The upcoming Amazon availability represents another step in NWB Finland Oy’s strategy to introduce AINA Natural Water to U.S. consumers. The company previously announced that AINA would become available through OneLavi.com, marking the first opportunity for U.S. consumers to purchase the brand. “Expanding to Amazon is an important next step for AINA in the United States,” said Marita Weiman, Quality Assurance Manager at NWB Finland Oy. “We want to make it easy for consumers to discover and purchase AINA while introducing them to what makes Northern Finnish water and our packaging approach different.” AINA Natural Water originates in the Pudasjärvi region of Northern Finland, where groundwater is naturally filtered through layers of soil, sand and rock before being mechanically filtered and packaged. The water contains approximately 32 mg/L of Total Dissolved Solids (TDS). Its naturally low mineral content contributes to a soft, neutral taste and clean finish with no aftertaste. Premium Water Designed for Everyday Living NWB Finland Oy has built AINA around the idea that premium water should be practical enough to become part of everyday life. Instead of focusing on individual plastic bottles, AINA is offered in larger 5-liter and 10-liter bag-in-box formats designed for convenient use at home, at work and in other everyday settings. The sustainability-focused packaging uses substantially less plastic than comparable volumes packaged in traditional individual plastic bottles. The approach combines three elements NWB Finland Oy believes can differentiate AINA in the U.S. market: Northern Finland source Naturally low mineral profile Sustainability-Focused Packaging AINA’s upcoming expansion to Amazon follows a series of steps by NWB Finland Oy to establish the brand in the United States. The company recently participated in the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida, where AINA and its bag-in-box format were introduced to U.S. retail buyers. “We are building AINA’s U.S. presence step by step,” Weiman said. “Amazon will significantly broaden the opportunity for consumers across the country to experience AINA Natural Water.” The AINA Difference Northern Finland Source - Originates in the Pudasjärvi region of Northern Finland, an area known for its forests, natural landscapes, and groundwater resources. Naturally Filtered - Groundwater is naturally filtered through layers of soil, sand, and rock before being mechanically filtered and packaged. Measured Purity - Contains approximately 32 mg/L of Total Dissolved Solids (TDS), contributing to a soft, clean taste profile. Clean Taste Profile - Naturally low mineral content helps provide a balanced drinking experience with no aftertaste. Naturally Low in Sodium - Contains only small amounts of sodium and dissolved minerals. Sustainability-Focused Packaging - Bag-in-box packaging uses substantially less plastic than traditional bottled-water formats. Additional details about Amazon availability will be announced when AINA Natural Water becomes available for purchase. For more information about AINA Natural Water, visit AINA Natural Water. To learn more about NWB Finland Oy, visit NWB Finland Oy. About NWB Finland Oy NWB Finland Oy is a Finland-based company focused on sustainable beverage packaging and natural water solutions. Headquartered in Pudasjärvi, Finland, the company was founded with a mission to develop environmentally responsible alternatives to traditional beverage packaging while delivering premium-quality products to consumers around the world. Its flagship brand, AINA Natural Water, features naturally filtered groundwater sourced from Northern Finland, a region known for its pristine natural environment and abundant groundwater resources. The water is packaged in innovative bag-in-box formats designed to reduce plastic consumption while providing a convenient solution for households, businesses, hospitality venues, and events. NWB Finland Oy's long-term vision is to make Northern Finland's natural groundwater available to consumers globally while continuing to invest in sustainable packaging solutions that support both consumer needs and environmental responsibility.
  4. AIWolfson Group To Bring Multi-Category Wellness Portfolio to OneLaviBoca Raton, Florida Friday Oct 9, 2026 @ 4:00 AM Eastern — Wolfson Group, a Scotland-based international consumer wellness company, today announced that three brands from its portfolio, PhenQ, TestoPrime, and YourBiology, are coming soon to OneLavi.com, marking another step in the company's strategy to expand U.S. distribution beyond Amazon. The upcoming OneLavi availability will provide another online destination for U.S. consumers to discover and purchase Wolfson Group brands while supporting the company's broader effort to build a diversified retail and e-commerce presence in the United States. "Expanding onto OneLavi is another important step in making our brands more accessible to consumers across the U.S.," said the founder and CEO of Wolfson Group. "Amazon has provided us with a strong foundation in the market, and we're now building on that presence by developing additional channels for our portfolio." The three brands coming to OneLavi represent distinct areas of the consumer wellness market. PhenQ focuses on weight management, TestoPrime serves the men's wellbeing category, and YourBiology focuses on women's gut health and everyday wellness. The expansion follows a series of U.S. initiatives by Wolfson Group as the Scotland-based company works to broaden its American presence. In September, Wolfson Group participated in the ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida, where the company introduced its multi-category portfolio during scheduled retail meetings. Wolfson Group has also been examining how consumer wellness interests increasingly extend across multiple categories, including weight management, cognitive wellness, gut health, men's and women's wellbeing and healthy ageing. The company believes its diversified portfolio provides opportunities to serve consumers with different wellness priorities throughout various stages of life. Adding OneLavi to Wolfson Group's U.S. distribution strategy reflects the company's approach of building multiple paths to the consumer rather than relying on a single marketplace or retail channel. "Our U.S. strategy is about creating a broader and more sustainable distribution footprint over time," the founder said. "Adding new online retail relationships complements what we've already built and gives us another foundation as we continue exploring opportunities across both e-commerce and brick-and-mortar retail." Wolfson Group said it will continue pursuing additional U.S. distribution opportunities while investing in consumer education, science-led brand development and long-term growth across its portfolio. PhenQ, TestoPrime, NooCube and YourBiology are already available to U.S. consumers through Amazon. Their upcoming availability on OneLavi will add another online retail channel as Wolfson Group continues building a broader U.S. distribution footprint. About Wolfson Group Wolfson Group is an international consumer wellness company focused on building science-led brands that help people live healthier lives. Its portfolio spans weight management, cognitive health, gut health, men's wellness, beauty and healthy ageing, serving millions of consumers worldwide through direct-to-consumer, marketplace and retail channels. Wolfson Group's portfolio includes the established wellness brands PhenQ, TestoPrime, NooCube and YourBiology, spanning categories such as weight management, cognitive wellness, gut health and men's wellbeing. The brands are currently available to U.S. consumers through Amazon while the company pursues broader retail opportunities nationwide.
  5. AIGoogle CloudCaixaBank Expands Strategic Collaboration with Google Cloud to Accelerate AI and Data CapabilitiesCompanies: Alphabet Inc.New agreement incorporates advanced generative AI, security, and infrastructure capabilities to drive technological transformation — CaixaBank today announced an expanded strategic agreement with Google Cloud, strengthening its...
  6. AI蘋果Home Hub傳聞升溫 家庭AI中樞的落地賽已開啟香港, 2026年10月9日 - 近期，據多家媒體援引 Bloomberg 報導，蘋果可能推出由 Siri AI 驅動的家庭中樞產品。圍繞「Home Hub」的討論升溫，再次讓家庭 AI 中樞成為科技行業關注的焦點。 這背後所指向的，並不只是一台帶螢幕、帶語音的新硬體。家庭正在成為 AI 從數字世界走向真實物理場景的重要入口：它需要連接分散的設備、理解家庭成員與場景，並協調娛樂、安防、資訊與日常服務。家庭 AI 中樞的核心競爭，也正在從「設備互聯」走向「智能體、終端與服務的協同」。 這一趨勢，與華曦達正在推進的 AI Home 路徑高度契合。依託長期積累的家庭視訊、OTT、Android TV 等終端和平台能力，華曦達正把原有的家庭娛樂入口延展為面向 AI Home 的服務承載節點——AI Home Hub。 華曦達所探索的，不是為傳統設備簡單疊加 AI 功能，而是以家庭終端為觸點，連接雲端智能、家庭設備、內容
  7. AI蘋果Home Hub傳聞升溫 家庭AI中樞的落地賽已開啟香港, 2026年10月9日 - 近期，據多家媒體援引 Bloomberg 報導，蘋果可能推出由 Siri AI 驅動的家庭中樞產品。圍繞「Home Hub」的討論升溫，再次讓家庭 AI 中樞成為科技行業關注的焦點。 這背後所指向的，並不只是一台帶螢幕、帶語音的新硬體。家庭正在成為 AI 從數字世界走向真實物理場景的重要入口：它需要連接分散的設備、理解家庭成員與場景，並協調娛樂、安防、資訊與日常服務。家庭 AI 中樞的核心競爭，也正在從「設備互聯」走向「智能體、終端與服務的協同」。 這一趨勢，與華曦達正在推進的 AI Home 路徑高度契合。依託長期積累的家庭視訊、OTT、Android TV 等終端和平台能力，華曦達正把原有的家庭娛樂入口延展為面向 AI Home 的服務承載節點——AI Home Hub。 華曦達所探索的，不是為傳統設備簡單疊加 AI 功能，而是以家庭終端為觸點，連接雲端智能、家庭設備、內容服務與運營商業務體系，形成可部署、可運營、可持續演進的家庭服務能力。面向家庭娛樂、家庭安防、設備協同與日常生活服務等多元場景，AI Home Hub 有望讓家庭服務從「響應一次指令」，逐步走向「理解上下文、協同多終端與多服務」。 作為 AI Home 第一股，華曦達長期服務全球運營商市場，正以家庭終端產品基礎、平台能力和全球交付經驗，加快 AI Home 在真實家庭場景中的驗證與產品化落地。當蘋果相關報導帶來新的市場關注，華曦達正在回答的則是更具實踐意義的問題：如何讓家庭 AI 中樞真正進入運營商服務體系，進入更多用戶家庭。
  8. AI苹果Home Hub传闻升温 家庭AI中枢的落地赛已开启香港, 2026年10月9日 - (亚太商讯) - 近期，据多家媒体援引 Bloomberg 报道，苹果可能推出由 Siri AI 驱动的家庭中枢产品。围绕“Home Hub”的讨论升温，再次让家庭 AI 中枢成为科技行业关注的焦点。 这背后所指向的，并不只是一台带屏幕、带语音的新硬件。家庭正在成为 AI 从数字世界走向真实物理场景的重要入口：它需要连接分散的设备、理解家庭成员与场景，并协调娱乐、安防、信息与日常服务。家庭 AI 中枢的核心竞争，也正在从“设备互联”走向“智能体、终端与服务的协同”。 这一趋势，与华曦达正在推进的 AI Home 路径高度契合。依托长期积累的家庭视讯、OTT、Android TV 等终端和平台能力，华曦达正把原有的家庭娱乐入口延展为面向 AI Home 的服务承载节点——AI Home Hub。 华曦达所探索的，不是为传统设备简单叠加 AI 功能，而是以家庭终端为触点，连接云端智能、家庭设备、内容服务与运营商业务体系，形成可部署、可运营、可持续演进的家庭服务能力。面向家庭娱乐、家庭安防、设备协同与日常生活服务等多元场景，AI Home Hub 有望让家庭服务从“响应一次指令”，逐步走向“理解上下文、协同多终端与多服务”。 作为 AI Home 第一股，华曦达长期服务全球运营商市场，正以家庭终端产品基础、平台能力和全球交付经验，加快 AI Home 在真实家庭场景中的验证与产品化落地。当苹果相关报道带来新的市场关注，华曦达正在回答的则是更具实践意义的问题：如何让家庭 AI 中枢真正进入运营商服务体系，进入更多用户家庭。 Copyright 2026 亚太商讯. All rights reserved. www.acnnewswire.com
  9. AIOpenAIAsana cuts model costs 76x in browser tests with GPT-6.1 SolCompanies: OpenAIUsing GPT-6 Astra in Codex, Asana made its browser agent 76x cheaper and 5x faster in tests to offer customers more capable models.
  10. AITwo Former Moderna Cancer Vaccine Scientists Join Everest Medicines, Accelerating Global Development of Its mRNA PlatformHong Kong, Oct 9, 2026 - Everest Medicines (1952.HK) announced the appointments of Lakshmi Srinivasan, PhD, as Senior Vice President, Head of Translational Medicine, and Brandon Coder, PhD, as Vice President, Translational Sciences & Discovery. Both executives are seasoned scientists in mRNA cancer vaccines, with deep experience spanning early discovery through clinical development and leadership roles in oncology vaccine research at Moderna and other leading biopharmaceutical companies. The appointments further strengthen the Company’s global R&D capabilities in mRNA therapeutics, and support the continued advancement of its proprietary mRNA platform and pipeline. At Everest, they will drive clinical development of the Company’s mRNA programs and expand Everest’s presence in the United States, in line with the Company’s global mRNA R&D strategy, while working closely with the China R&D team. The two scientists previously held leadership roles at Moderna, where they contributed to its mRNA cancer vaccine programs, including mRNA-4157/V940. Their experience spanning early-stage research through clinical development will support the advancement of Everest's proprietary mRNA platform and global clinical development programs. In August 2026, Moderna and Merck announced that mRNA-4157/V940 in combination with Keytruda met the primary endpoint of recurrence-free survival (RFS) and the key secondary endpoint of distant metastasis-free survival (DMFS) in the Phase 3 INTerpath-001 study. The results represent the first positive Phase 3 readout for an individualized neoantigen therapy (INT) and for an mRNA-based cancer therapy. “We are very pleased to welcome Dr. Srinivasan and Dr. Coder to Everest Medicines as we continue to strengthen our global mRNA R&D capabilities,” said Mr. Yifang Wu, Chairman of the Board of Everest Medicines. “Their deep experience in cancer vaccine research, translational medicine, and clinical development will be highly valuable as we advance our proprietary mRNA platform and broader pipeline. Their appointments reflect our continued commitment to investing in world-class talent and advancing our global mRNA strategy.” Dr. Srinivasan is a seasoned immunologist with 20 years of experience advancing innovative immuno-oncology therapeutics from discovery through clinical development. Her expertise spans cancer vaccines, mRNA-LNP technologies, T-cell therapies, and translational development from preclinical research through clinical proof of concept. Prior to joining Everest Medicines, Dr. Srinivasan served as Executive Director and Head of Oncology Translational Medicine at Moderna Therapeutics from 2023 to 2025. She previously held leadership roles at Repertoire Immune Medicines, Neon Therapeutics, which was later acquired by BioNTech, and Sanofi Oncology. Dr. Srinivasan has played a key role in the clinical translation of personalized neoantigen vaccines and has authored multiple high-profile publications in the field. She served as corresponding author on Phase 1b studies of NEO-PV-01 published in Cell (2020) and Cancer Cell (2022), and co-authored publications on Moderna’s intismeran autogene (mRNA-4157/V940), including the Phase 1 KEYNOTE-603 study published in Cancer Discovery (2024) and the three-year follow-up of the randomized Phase 2b KEYNOTE-942 study published in JCO Oncology Advances (2026). Dr. Coder brings more than 11 years of industry experience advancing T cell immunotherapies from discovery through investigational new drug (IND) submissions and early clinical proof of concept, with expertise in cancer vaccines, mRNA/LNP platform technology, and in vivo CAR therapies. Prior to joining Everest Medicines, Dr. Coder held scientific roles at Moderna from 2019 to 2025, most recently as Associate Scientific Director of Cancer Vaccine Research. He served as research and global pharmacology lead for intismeran autogene (mRNA-4157/V940), which reported positive results from the Phase 3 INTerpath-001 study in August 2026, becoming the first personalized neoantigen therapy and mRNA cancer therapy to achieve success in a Phase 3 clinical study. Dr. Coder also co-invented and led development of the shared-antigen discovery and vaccine design framework for mRNA-4359 and mRNA-4106. He contributed to nine IND submissions as a co-inventor, research lead, or core contributor, and co-authored the Phase 1 KEYNOTE-603 study of mRNA-4157/V940 published in Cancer Discovery (2024). Prior to joining Moderna, Dr. Coder served as Associate Director of Immuno-Oncology Research at Advaxis Immunotherapies, where he developed personalized and off-the-shelf cancer vaccines. Leveraging its proprietary AI+mRNA platform, Everest Medicines is advancing multiple mRNA oncology therapeutic vaccine and in vivo CAR-T programs for oncology and autoimmune diseases. EVM16, a personalized mRNA therapeutic cancer vaccine, has completed its first-in-human clinical data readout, demonstrating a favorable safety and tolerability profile, robust immunogenicity and promising preliminary efficacy. Selected data were presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting. Following the Phase 1a study, EVM16 plans to initiate an investigator-initiated trial (IIT) Phase 1b study in Q4 2026 and launch new indication expansion cohorts for efficacy exploration. The company plans to submit an IND application to the U.S. Food and Drug Administration (FDA) in the first half of 2027. EVM14, an off-the-shelf tumor-associated antigen (TAA) mRNA cancer vaccine, received IND clearance from the U.S. FDA and IND approval from China’s National Medical Products Administration (NMPA) in 2025. The Phase 1 monotherapy dose-escalation study is expected to be completed in Q1 2027.EVM18, an in vivo CAR-T therapy, has initiated an IIT study in autoimmune diseases, with global IND filing underway. EVM15, an off-the-shelf immunomodulatory (IM) cancer vaccine, achieved clinical proof of concept in preclinical studies in 2025, with a clinical candidate subsequently selected. The Company plans to advance preparations for the Investigational New Drug (IND) application for EVM15 in 2026.
  11. AIAirwheel Advances Smart Travel Through Award-Winning Rideable Ai Wheel 20inch Carry on boarding hand Luxury Cabin SuitcaseBRUSSELS, BELGIUM, Oct 9, 2026 - Most recently, the Airwheel SE3SX Smart Rideable Cabin Suitcase was honored with a 2026 European Product Design Award (EPDA) Winner title, marking yet another milestone in the brand's relentless pursuit of innovation. Airwheel, a pioneering smart mobility brand, has cemented its position as a global design leader with its intelligent rideable luggage series accumulating over 100 prestigious international awards across the United States, Europe, Japan, Italy, Germany, France, and London. The EPDA, alongside the MUSE Design Awards and IDEA Awards—all established by the International Awards Associate (IAA)—represent the pinnacle of global industrial design recognition. An international jury evaluates entries across innovation, aesthetic expression, practical implementation, human-machine interaction, and user experience. Airwheel's repeated success across these platforms underscores its design philosophy: "Let design return to real travel." Award-Winning Products Under the Spotlight Airwheel SE3S Smart Electric Suitcase Award Portfolio: 2023 MUSE Design Award, IDA Award, Italy IIDA Award; 2024 French Design Award, London Design Award (Best of Year), American Good Design Award (Silver), Paris DNA Design Award, NY Product Design Award (Silver); 2025 German National Design Award (Winner), Italy A' Design Award (Silver) MUSE Jury Commentary: "The Airwheel SE3S revolutionizes the traditional suitcase by integrating electric rideability with smart storage. Its patented high-strength frame and modular detachable lithium battery enable seated mobility while meeting stringent aviation regulations—delivering an effortless, elegant travel experience for frequent flyers." As the flagship pioneer of Airwheel's rideable luggage line, the SE3S features a 20-inch carry-on form factor combining rideable transportation, smart storage, and on-the-go charging. Its high-strength hard shell and patented reinforced frame support rider weight, while dual-handlebar controls ensure intuitive operation. The modular plug-and-play lithium battery requires no tools for removal and complies with civil aviation standards. Airwheel SE3SX Smart Rideable Cabin Suitcase Award Portfolio: 2026 European Product Design Award (Winner), WGA Creative Global Design Award (Silver), iLuxury International Luxury Award, Titan Innovation Award (Platinum) EPDA Jury Commentary: "The Airwheel SE3SX redefines the value boundary of carry-on luggage as a 'smart travel terminal,' seamlessly integrating high-performance electric drive, intelligent interaction, and aviation-grade lightweight design. Its innovative electric telescopic front-wheel structure enhances riding stability, while Apple Find My and a dedicated smart app deliver natural human-machine interaction. The 73.26Wh detachable battery and TSA lock ensure global compliance—a design benchmark for premium international business travel." The SE3SX packs a 230W high-performance brushless motor delivering speeds up to 9.9km/h, a 95kg load capacity, and 6° hill-climbing capability. Its innovative electric telescopic front-wheel structure extends the wheelbase by 180mm at the touch of a button. The body combines lightweight ABS+PC materials with an aviation-grade aluminum alloy frame, weighing approximately 6.6kg (excluding power bank), with dimensions of 530×360×236mm and a 20L capacity. Features include Apple Find My global tracking, a dedicated smart app, 5V USB charging, a detachable 73.26Wh lithium battery, and a TSA customs lock—approved for both air and high-speed rail travel. Airwheel SE3SXD Ai Luxury Suitcase The SE3SXD elevates the travel experience with an integrated smart interaction system and linked smart handle, enabling one-touch switching between suitcase form and riding mode. Its dual-drive automatic telescopic mechanism extends and retracts the structure with a single touch—transforming luggage into an intelligent travel companion. Airwheel SE3MiniT Electric Hand Suitcase Award Portfolio: 2024 European Design Award, London Design Award (Platinum), NY Product Design Award (Gold), American Good Design Award (Bronze), Paris DNA Award (Honorable Mention), French Design Award (Honorable Mention); 2025 Italy A' Design Award (Silver), World Design Award European Design Award Jury Commentary: "The Airwheel SE3MiniT addresses urban short-distance travel with ultimate lightweight design, distilling complex rideable luggage functions into a pure 'travel light' experience. Its compact form and convenient rideability make city commutes and weekend getaways effortless—showcasing nuanced thinking for segmented smart mobility scenarios." Designed for urban commuting and weekend excursions, the SE3MiniT retains Airwheel's signature rideable functionality in a compact, lightweight body—ideal for high-frequency, short-distance metropolitan travelers. Airwheel SE3SL / SE3SL+ Ai Wheel Airport Boarding Suitcase Award Portfolio: SE3SL—2025 Berlin Design Award (Gold), Shanghai Design Award, US IDEA Award, IAI Design Award, New Quality Award, Japan IDPA Design Award (Silver), 2026 Asian Design Award; SE3SL+—2025 US AIIDA Design Award, Boiling Quality Award (Gold) IDEA Jury Commentary: "The Airwheel SE3SL organically combines smart mobility concepts with mainstream business luggage forms. At just 6.6kg, its ultra-lightweight design integrates rideability, app connectivity, USB charging, and location tracking—achieving an outstanding balance between innovation, user experience, and commercial value. A mature offering for high-frequency business travel." Targeting premium business travelers, the SE3SL/SE3SL+ series integrates rideable transportation, smart app connectivity, USB charging, and Apple Find My tracking—blending aesthetics with practicality for both short-haul and international business scenarios. Airwheel SQ3S Smart Kids Suitcase Award Portfolio: 2025 French Design Award (Gold), MUSE Design Award (Silver), American Good Design Award (Bronze), NY Product Design Award (Gold) French Design Award Jury Commentary: "The Airwheel SQ3S enters the family travel scene with a safety-first design language, achieving a balance of 'storable, rideable, and reassuring' in a children's smart suitcase. Its safety speed-limit design fully considers children's riding safety, making family travel both fun and secure—embodying design's gentle care for real family needs." The SQ3S is Airwheel's dedicated smart suitcase for family travel, combining ample storage with child-friendly rideable fun, featuring a safety speed-limit design for secure, enjoyable family experiences. Meet Airwheel at the 140th Canton Fair Following its continued recognition in international design competitions, Airwheel invites distributors, importers, retailers, business partners, and visitors from around the world to meet its team at the 140th China Import and Export Fair (Canton Fair) in Guangzhou, China. Airwheel will participate across all three phases of the exhibition, presenting its intelligent rideable luggage and smart mobility solutions to international buyers and industry professionals. Visitors will have the opportunity to explore Airwheel’s product portfolio, experience selected products firsthand, learn more about its latest developments in smart travel technology, and discuss potential distribution partnerships and business opportunities. From smart rideable cabin suitcases to its latest intelligent luggage concepts, Airwheel looks forward to connecting with global partners and exploring opportunities to bring innovative mobility solutions to more markets. Global buyers and potential distribution partners are warmly invited to visit Airwheel’s booths and meet the team in person. Exhibition: 140th China Import and Export Fair (Canton Fair) Venue: China Import and Export Fair Complex, Guangzhou, China Phase 2: October 23–27, 2026 | Booth 20.2F19–20 Phase 3: October 31–November 4, 2026 | Booth 20.2J37–38,20.2K11-12, 18.1K04 For international buyers seeking to expand their smart luggage portfolio, explore retail opportunities, or discuss regional distribution, the Canton Fair provides an opportunity to connect directly with Airwheel and learn more about its products and international partnership opportunities. Brand-Level Honors and Future Outlook As a pioneer of the smart rideable luggage category, Airwheel has built a clear and robust competitive moat through core technologies. To date, the company has secured over 600 patents globally, covering motion control algorithms, electric drive systems, intelligent perception, and structural design—including multiple international invention patents. Airwheel's trademarks are registered in over 168 countries and regions, providing a solid foundation for compliant operations, scalable promotion, and long-term brand building across diverse markets. Behind these honors lies over a decade of deep cultivation in the smart mobility sector. From its first German iF Design Award to now holding over 100 international certifications across the US, Europe, Japan, Italy, France, and the UK, Airwheel continues to showcase the power of persistent innovation. Looking ahead, the brand will continue integrating cutting-edge intelligent perception and human-machine interaction technologies—embedding technology into every journey and delivering smart mobility innovations to global markets. About Airwheel Airwheel is a leading smart mobility brand specializing in intelligent rideable luggage and personal mobility solutions. Guided by its design philosophy “Let design return to real travel”, Airwheel combines electric drive, smart interaction and aviation-grade materials to redefine travel experiences. Boasting over 600 global patents and more than 100 international awards, Airwheel, as one of the world’s leading smart mobility device manufacturers, strives to unleash the joy of technology and uphold its corporate culture: “Free Intelligent Life”. Media Contact Company: Airwheel Contact: Media Team Website: https://www.airwheel.net
  12. FinanceFullerton and SGX Group open second Value-Up Singapore Equities Challenge to the public with new Open CategorySINGAPORE, Oct 9, 2026 - Fullerton Fund Management (“Fullerton”) and SGX Group, in partnership with Moomoo Singapore as Supporting Partner, launched the second edition of the Fullerton / SGX Value-Up Singapore Equities Challenge(1) (“The Challenge”) to the public for the first time, inviting Singaporeans and Permanent Residents aged 18 and above to test their investing skills on Singapore-listed small and mid-cap companies over eight weeks, with cash prizes for the top performers. The inaugural Challenge in 2025 was open to students only. This year’s edition adds an Open Category for the public while retaining the Student Category. Participants in both categories will research and manage virtual portfolios of eligible Singapore-listed securities, with a focus on Singapore’s small- and mid-cap (“SMID”) segment. The trading simulation does not involve real capital. The Challenge comes as interest in Singapore’s SMID segment grows. As of 30 June 2026, institutional net buying in SMID stocks had tripled year on year to S$606 million, while daily trading value rose 155% to S$310 million, its highest level since FY2014(2). The Challenge gives participants a structured and practical way to learn more about companies beyond the Straits Times Index. Open Category Open to Singapore Citizens and Permanent Residents aged 18 and above, the Open Category will run from 7 December 2026 to 29 January 2027 over an eight-week online trading period. Participants compete individually, constructing and managing portfolios from an eligible list of Singapore-listed securities. They will be ranked in real time on a leaderboard based on total portfolio return, with cash prizes of S$3,000, S$2,000 and S$1,000 for the top three participants. Student Category The Student Category returns for its second year and is open to Singapore Citizens and Permanent Residents aged 18 and above who are enrolled full-time in polytechnics or universities. Participants compete in teams of four in the same eight-week simulation, using eligible Singapore-listed securities focused primarily on the SMID segment. The top six teams from the qualifying round will advance to an in-person stock-pitch final, where they will present their research and investment thesis to a judging panel. The top three teams will receive cash prizes of S$10,000, S$5,000 and S$3,000. The category is designed to connect classroom learning with practical exposure to investing, industry practitioners and potential 8-month internship opportunities, through the Fullerton Singapore Value-Up Internship Programme. Building disciplined investment habits The Challenge is designed to encourage disciplined portfolio construction rather than concentrated bets. Participants must establish positions within the first five trading days. From 14 December 2026, portfolios must maintain at least 80% exposure to eligible securities at the end of each trading day, with cash holdings capped at 20%. When initiating or adding to a position, exposure to any individual eligible security must not exceed 10% of the portfolio’s total value. Each portfolio may hold no more than 30 eligible securities; leverage, margin and derivatives are not permitted. Through the Challenge, participants will be able to: Gain first-hand experience in researching and evaluating Singapore-listed companies. Develop practical habits around portfolio construction, risk management and investment decision-making. Build a stronger understanding of opportunities available within Singapore’s equities market beyond the benchmark index. Ken Goh, Chief Investment Officer, Fullerton Fund Management, said: “Over the past year, we have seen growing interest in Singapore equities, reflecting broader recognition of the depth and diversity of our domestic market. The objective of the Fullerton/SGX Value-Up Singapore Equities Challenge is to motivate participants to identify and capture rising shareholder value, by encouraging young investors and members of the public to research companies, assess their potential and construct portfolios with greater discipline. The Challenge also supports our broader commitment to talent development. Participants from the inaugural Challenge have since joined Fullerton as interns, demonstrating how practical exposure can help inspire and nurture the next generation of investment professionals. Through this Challenge, we hope to contribute to a more informed and engaged Singapore equities market, with a broader base of investors participating in its long-term development.” Ng Yao Loong, Head of Global Financial Markets, SGX Group, said: “In every market, there is a difference between what is well known and what is well understood. The Fullerton/SGX Value-Up Singapore Equities Challenge encourages participants to close that gap by researching the SMID segment, testing their assumptions and forming their own investment perspectives. By opening the Challenge to the public, we hope more people will discover the breadth of the Singapore stock market and deepen their understanding of the businesses behind it.” Jeyson Ng, CEO, Moomoo Singapore said: “We are pleased to support Fullerton and SGX, both of whom are Moomoo’s long-term strategic partners in the Singapore ecosystem, in making investing education more accessible to students and the wider public. Through practical learning resources on Singapore equities, company research and portfolio construction within the Moomoo app, we hope to help participants build the confidence and foundational skills to better understand the market. The Challenge also provides a meaningful platform for us to engage aspiring talent and nurture the next generation of finance and technology professionals.” Registration for both categories is open until 30 November 2026. A participant may register for either the Student Category or the Open Category (provided that it meets the relevant eligibility requirements), but not both. Interested parties may sign up at https://value-up.investsg.asia/ (1) Jointly developed by SGX Group and AlphaInvest (2) SGX Group Research About Fullerton Fund Management Fullerton Fund Management Company Ltd (“Fullerton”) is an active investment specialist, focused on optimising investment outcomes and enhancing investor experience. We help clients, including government entities, sovereign wealth funds, pension plans, insurance companies, private wealth and retail, from the region and beyond, to achieve their investment objectives through our suite of solutions. Our expertise encompasses equities, fixed income, multi-asset, alternatives and treasury management, across public and private markets. As an active manager, we place strong emphasis on performance, risk management and investment insights. Incorporated in 2003, Fullerton is headquartered in Singapore, and has associated offices in Shanghai, Brunei and Jakarta. Fullerton is part of a multi-asset management group, Seviora, a holding company established by Temasek. Income Insurance, one of Singapore’s leading insurers, is a minority shareholder of Fullerton. For more information, please visit www.fullertonfund.com About SGX Group (Singapore Exchange) SGX Group is one of the world’s most trusted international marketplaces, known for its stability and openness. Anchored in Singapore, we enable price discovery, capital formation and risk management across asset classes, supported by resilient infrastructure and robust clearing. We convene issuers, investors and intermediaries to create and grow markets that stand the test of time. Find out more at www.sgxgroup.com. About Moomoo Singapore Moomoo Singapore is a holistic wealth-tech platform building an intelligent investing ecosystem across its digital platform, physical experience stores and investor education community. Through the moomoo app, it provides everyday investors and professional clients with access to global markets, diverse investment products, advanced trading tools and AI-powered insights. Since launching in March 2021, Moomoo Singapore has evolved beyond an investing platform into a popular financial literacy resource and full-spectrum wealth platform, supporting investors from their first trade to managing sophisticated portfolios. It surpassed two million users in Singapore in June 2026, spanning retail investors to private wealth and institutional clients. Moomoo Financial Singapore Pte. Ltd. is a subsidiary of Nasdaq-listed Futu Holdings Limited (Nasdaq: FUTU). The firm is regulated by the Monetary Authority of Singapore and holds a Capital Markets Services Licence (CMS101000) and Major Payment Institution Licence (PS20200617). It also has exempt financial adviser status and is authorised to provide Digital Payment Token services. Moomoo Trustee (Singapore) Pte. Ltd. is a licensed trust company, while Moomoo Singapore is a DP Clearing Member, SGX-ST Trading Member, and SGX-DT Trading and Clearing Member of Singapore Exchange. Find out more at https://www.moomoo.com/sg For media queries, please contact: Rishika Tiwariemail: [email protected]